Back to Search Start Over

Autoradiographical assessment of inflammation-targeting radioligands for atherosclerosis imaging: potential for plaque phenotype identification.

Authors :
Meester, Eric J.
de Blois, Erik
Krenning, Boudewijn J.
van der Steen, Antonius F. W.
Norenberg, Jeff P.
van Gaalen, Kim
Bernsen, Monique R.
de Jong, Marion
van der Heiden, Kim
Source :
EJNMMI Research; 3/17/2021, Vol. 11 Issue 1, p1-10, 10p
Publication Year :
2021

Abstract

Purpose: Many radioligands have been developed for the visualization of atherosclerosis by targeting inflammation. However, interpretation of in vivo signals is often limited to plaque identification. We evaluated binding of some promising radioligands in an in vitro approach in atherosclerotic plaques with different phenotypes. Methods: Tissue sections of carotid endarterectomy tissue were characterized as early plaque, fibro-calcific plaque, or phenotypically vulnerable plaque. In vitro binding assays for the radioligands [<superscript>111</superscript>In]In-DOTATATE; [<superscript>111</superscript>In]In-DOTA-JR11; [<superscript>67</superscript>Ga]Ga-Pentixafor; [<superscript>111</superscript>In]In-DANBIRT; and [<superscript>111</superscript>In]In-EC0800 were conducted, the expression of the radioligand targets was assessed via immunohistochemistry. Radioligand binding and expression of radioligand targets was investigated and compared. Results: In sections characterized as vulnerable plaque, binding was highest for [<superscript>111</superscript>In]In-EC0800; followed by [<superscript>111</superscript>In]In-DANBIRT; [<superscript>67</superscript>Ga]Ga-Pentixafor; [<superscript>111</superscript>In]In-DOTA-JR11; and [<superscript>111</superscript>In]In-DOTATATE (0.064 ± 0.036; 0.052 ± 0.029; 0.011 ± 0.003; 0.0066 ± 0.0021; 0.00064 ± 0.00014 %Added activity/mm<superscript>2</superscript>, respectively). Binding of [<superscript>111</superscript>In]In-DANBIRT and [<superscript>111</superscript>In]In-EC0800 was highest across plaque phenotypes, binding of [<superscript>111</superscript>In]In-DOTA-JR11 and [<superscript>67</superscript>Ga]Ga-Pentixafor differed most between plaque phenotypes. Binding of [<superscript>111</superscript>In]In-DOTATATE was the lowest across plaque phenotypes. The areas positive for cells expressing the radioligand's target differed between plaque phenotypes for all targets, with lowest percentage area of expression in early plaque sections and highest in phenotypically vulnerable plaque sections. Conclusions: Radioligands targeting inflammatory cell markers showed different levels of binding in atherosclerotic plaques and among plaque phenotypes. Different radioligands might be used for plaque detection and discerning early from vulnerable plaque. [<superscript>111</superscript>In]In-EC0800 and [<superscript>111</superscript>In]In-DANBIRT appear most suitable for plaque detection, while [<superscript>67</superscript>Ga]Ga-Pentixafor and [<superscript>111</superscript>In]In-DOTA-JR11 might be best suited for differentiation between plaque phenotypes. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
2191219X
Volume :
11
Issue :
1
Database :
Complementary Index
Journal :
EJNMMI Research
Publication Type :
Academic Journal
Accession number :
149336221
Full Text :
https://doi.org/10.1186/s13550-021-00772-z